TFSA Investors: Should the HMMJ ETF Be Part of Your Portfolio?

The HMMF ETF gives investors an opportunity to access the high-risk, high-reward cannabis space.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

When you invest your savings in the equity markets, you aim to beat the broader markets and grow long-term wealth. One of the best strategies to achieve your financial goals at an accelerated pace is to buy and hold quality growth stocks. So, you need to identify companies that are part of a rapidly expanding addressable market.

Once you identify these stocks, you can hold them in your TFSA, or Tax-Free Savings Account. The TFSA is a registered account, and any withdrawals in the form of dividends, capital gains, and even interest are exempt from Canada Revenue Agency taxes. The TFSA seems to be a solid option to buy and hold growth stocks, allowing investors to benefit from exponential gains over time.

Companies that are part of the cannabis space have the potential to increase your savings multifold due to the prospects of marijuana legalization in the U.S. and several other regions. According to a report from Grand View Research, the global legal cannabis market might touch US$70.6 billion by 2028, indicating an annual growth rate of 26.7% in the next seven years, making it an extremely lucrative sector.

The cannabis sector carries significant risk

Canadian cannabis companies were on an absolute tear just before the country legalized marijuana for recreational use. However, since the start of 2019, cannabis stocks have grossly underperformed the broader markets.

The optimism surrounding pot legalization quickly faded in the background, as cannabis companies were impacted by a slew of structural issues, including the slower-than-expected rollout of retail stores in major provinces, overvalued acquisitions, competition from a thriving black market, negative profit margins, and much more. This in turn resulted in high inventory levels, a high cash-burn rate, shareholder dilution, as well as multi-million-dollar writedowns.

Canadian cannabis stocks such as Aurora Cannabis, HEXO, Canopy Growth, and Cronos Group are trading 95%, 89%, 69%, and 71%, respectively, below record highs. However, the possibility of marijuana legalization at the federal level south of the border and other international markets might provide cannabis stocks an opportunity to gain momentum once again.

Investors should note that the cannabis sector is still at a nascent stage and can be compared to the dot com bubble of early 2000. It means this space will attract several players, increasing competition as well as consolidation in the upcoming years. There will be a few winners that will grow your investments at a stellar rate. But several other companies may go bankrupt due to the above-mentioned issues.

The HMMJ ETF offers you exposure to the cannabis space

In case you want to invest in the cannabis sector, purchasing an exchange-traded fund like Horizons Marijuana Life Sciences ETF (TSX:HMMJ) might be the best option. An ETF will provide investors exposure to several stocks, thereby reducing overall risk.

The HMMJ ETF aims to replicate the performance of the North American Marijuana Index. The ETF is rebalanced quarterly and provides investors access to a basket of publicly listed life sciences companies in the marijuana industry.

The top holdings of the HMMJ include Tilray, Innovative Industrial Properties, Cronos Group, and Canopy Growth; they account for more than 50% of the index fund. The HMMJ ETF has gained 36% in the last year but is still trading 56% below its all-time high, allowing cannabis investors to buy the dip.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Innovative Industrial Properties. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »